Which thyroid medications and bio-identical T4, T3 equivalents qualify to be included on Med safe’s safe medicines list?
Belinda Hodson made this Official Information request to Ministry of Health
The request was partially successful.
From: Belinda Hodson
Dear Ministry of Health,
Department of the Ministry: Medsafe,
1. For each of the years 1960, 1970, 1980, 1990, 2000, 2010 and
2015, what of the following have met the criteria to be listed on Med Safe’s safe medicines list; and under what criteria. Please provide the
breakdown by:
(a) all thyroid medications e.g. Synthroid, Cytomol, Eltroxin, and
(b) all Natural Desiccated Thyroid (NDT) equivalents to these
medications (note that NDTs are also called bio-identical hormones)
e.g. Whole Thyroid Extract, Extended Release T3.
2. What are the current criteria thyroid medications and/or the NDT
equivalents such as Whole Thyroid Extract need to meet to qualify to be included on the Medsafe safe medicines list?
3. What is the current process (as it applied to thyroid treatment)
that is used to set these criteria, specifically:
a. What are the inputs to this process e.g. types of research and
source(s); who is consulted e.g. type of medical specialist or
medical agency.
b. Who ultimately decides whether a medication/NDT meets the
criteria?
c. How are patients’ actual experiences of being on these
medications/NDTs represented in this process?; and what New Zealand
and/or overseas patient data e.g. medical records of patients, are
used to substantiate this? And, who provides this information? And
who funds this information (as funders and providers may be
different entities).
4. Have NDTs ever been up for consideration for inclusion on Med Safe’s safe medicines list?
a. If not, then why not? and
b. If they have, then in what year did this happen? Which of the
criteria did they meet and which of the criteria did they not meet.
What was the outcome of the consideration and on what basis were
they declined or accepted?
5. Have thyroid medications containing T3 e.g. Cytomol, ever been
up for consideration for inclusion on Med safe’s safe medicines list?
a. If not, then why not? and
b. If they have, then in what year did this happen? Which of the
criteria did they meet and which of the criteria did they not meet;
what was the outcome of the consideration and on what basis were
they declined or accepted?
Yours faithfully,
Belinda Hodson
Ministry of Health
Dear Ms Hodson
Thank you for your request for official information, received by the
Ministry of Health on 03 August 2015, requesting:
1. For each of the years 1960, 1970, 1980, 1990, 2000, 2010 and
2015, what of the following have met the criteria to be listed on Med
Safe’s safe medicines list; and under what criteria. Please provide the
breakdown by:
(a) all thyroid medications e.g. Synthroid, Cytomol, Eltroxin, and
(b) all Natural Desiccated Thyroid (NDT) equivalents to these medications
(note that NDTs are also called bio-identical hormones) e.g. Whole Thyroid
Extract, Extended Release T3.
2. What are the current criteria thyroid medications and/or the NDT
equivalents such as Whole Thyroid Extract need to meet to qualify to be
included on the Medsafe safe medicines list?
3. What is the current process (as it applied to thyroid treatment) that
is used to set these criteria, specifically:
a. What are the inputs to this process e.g. types of research and
source(s); who is consulted e.g. type of medical specialist or medical
agency.
b. Who ultimately decides whether a medication/NDT meets the criteria?
c. How are patients’ actual experiences of being on these medications/NDTs
represented in this process?; and what New Zealand and/or overseas patient
data e.g. medical records of patients, are used to substantiate this? And,
who provides this information? And who funds this information (as funders
and providers may be different entities).
4. Have NDTs ever been up for consideration for inclusion on Med Safe’s
safe medicines list?
a. If not, then why not? and
b. If they have, then in what year did this happen? Which of the criteria
did they meet and which of the criteria did they not meet. What was the
outcome of the consideration and on what basis were they declined or
accepted?
5. Have thyroid medications containing T3 e.g. Cytomol, ever been up for
consideration for inclusion on Med safe’s safe medicines list?
a. If not, then why not? and
b. If they have, then in what year did this happen? Which of the criteria
did they meet and which of the criteria did they not meet; what was the
outcome of the consideration and on what basis were they declined or
accepted?
Your request has been received and logged. As required under the Official
Information Act 1982, the Ministry will respond to your request within 20
working days. You should receive a response on or before 31 August 2015.
If a large amount of information has been requested or if the Ministry
needs to consult in order to make a decision, we may need to extend this
date (this is provided for in section 15A of the Act). We will advise you
if such an extension is necessary.
The Ministry's reference number for your request is: H201503268
Yours sincerely
Ashley Goodwin
OIA Co-ordinator l Government Relations l Office of the Director General
****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************
--------------------------------------------------------------------------
This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway
--------------------------------------------------------------------------
hide quoted sections
Ministry of Health
Sarah Reader | Manager | Product Regulation | Medsafe | Ministry of Health
| (04) 819 6836 |
----- Forwarded by Sarah Reader/MOH on 18/08/2015 09:09 a.m. -----
From: [email address]
To: [email address],
Date: 17/08/2015 02:56 p.m.
Subject: Scan Data from MFD-FRB-6-3
--------------------------------------------------------------------------
Sent by: sreader [[email address]]
Number of Images: 4
Attachment File Type: PDF
Device Name: MFD-FRB-6.3
Device Location:
****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************
--------------------------------------------------------------------------
This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway
--------------------------------------------------------------------------
hide quoted sections
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence
Offensive? Unsuitable?
Requests for personal information and vexatious requests are not considered valid requests for Official Information (read more).
If you believe this request is not suitable, you can report it for attention by the site administrators
Report this request